Kerala Journal of Ophthalmology

REVIEW ARTICLE
Year
: 2022  |  Volume : 34  |  Issue : 2  |  Page : 98--103

Update on imaging and anti-VEGF therapy for diabetic retinopathy


Sagnik Sen1, Sobha Sivaprasad2 
1 Department of Retina, Aravind Eye Hospital, Madurai, Tamil Nadu, India
2 Department of Retina, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

Correspondence Address:
Prof. Sobha Sivaprasad
Moorfields Eye Hospital NHS Foundation Trust, 162, City Road, London
United Kingdom

The classification of diabetic retinopathy has been based on 7-field photographs. With advances in retinal imaging, there is an unmet need to reclassify this condition as new predictive factors have been identified in the peripheral retina. In addition, we have transitioned from an era of laser treatment for vision-threatening complications to robust evidence that anti-VEGF therapy can modulate the diabetic retinopathy scores. In this review, the literature on both retinal imaging and role of anti-VEGF on diabetic retinopathy highlights both the merits and shortcomings of available evidence in this area.


How to cite this article:
Sen S, Sivaprasad S. Update on imaging and anti-VEGF therapy for diabetic retinopathy.Kerala J Ophthalmol 2022;34:98-103


How to cite this URL:
Sen S, Sivaprasad S. Update on imaging and anti-VEGF therapy for diabetic retinopathy. Kerala J Ophthalmol [serial online] 2022 [cited 2022 Sep 29 ];34:98-103
Available from: http://www.kjophthal.com/article.asp?issn=0976-6677;year=2022;volume=34;issue=2;spage=98;epage=103;aulast=Sen;type=0